169 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Buyback programs - May 2024 Monthly communication regarding buyback programs |
Liquidity contract | ||
2024 Annual General Assembly - results Results in French |
Shareholders´s Meeting | ||
Assemblée Générale Annuelle de Vetoquinol SA 28 mai 2024 Ordre du jour : |
Shareholders´s Meeting | ||
Buyback programs - April 2024 Monthly communication regarding buyback programs |
Liquidity contract | ||
BALO : Notice of meeting Shareholders are invited to attend the Combined General Meeting to be held on Tuesday May 28, 2024 at 11 a.m. at the Company's registered office, Magny-Vernois 70 200 LURE, in order to deliberate on the following agenda and draft resolutions |
Shareholders´s Meeting | ||
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
Press releases communication | ||
Rapport financier semestriel 2023 (french) Rapport financier semestriel 2023 (french) |
Half Year Report | ||
2023 Half-Year Results Contents |
Half Year Report | ||
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
Press releases communication | ||
Rapport financier semestriel 2022 (french) Rapport financier semestriel 2022 (french) |
Half Year Report |